ICIS has a network of locally based reporters providing coverage of regional Cyclohexane markets. They provide not just pricing information, but an in-depth understanding of the factors driving prices and market fluctuations.
Use ICIS information to:
- Develop internal analytical models
- Inform settlements and contracts
- Optimise deals and negotiations
Cyclohexane news and market information products from ICIS
We offer the following regional Cyclohexane coverage to keep you informed of factors and developments affecting prices in the Europe Cyclohexane marketplace.
Price Reporting – More information about the price reports we publish on Cyclohexane
Independent price assessments and market coverage
Price History – More information about the historical price data we publish on Gas
Track historical price data
News & analysis
News & Analysis - News & market analysis specifically relating to Cyclohexane
Breaking news of latest developments affecting the markets.
Insight and analysis of factors driving prices.
Updated to Q4 2017
Market tightness gradually eased in the fourth quarter as supply levels increased. European producer CEPSA conducted a planned shutdown during November although this had little impact on the market as European production ran smoothly during the quarter. Downstream planned maintenances also helped to ease supply tightness at the start of the quarter. From November onwards, a steady flow of imports reached the European market from the Middle East, the US and Asia.
Demand has been strong all year due to market tightness, but was slightly lower at the beginning of the quarter as planned maintenances were carried out at downstream European producers Solvay and Lanxess. This contributed to the creation of a balanced market, along with the healthy supply levels available as the quarter progressed. Demand returned to a healthy level in November and remained steady up until the end of the year. Negotiations for the first-quarter 2018 cyclohexane (CX) delta contract began in the last working week of December.
ICIS provides pricing information, news and analysis for all major petrochemical and chemical markets, including Cyclohexane.
We offer unbiased and independent price reporting, with our price assessments being widely quoted as benchmarks in contracts.
Our information is collected from market participants by our global network of reporters, delivering unrivalled coverage of established and emerging markets, including China and Asia.
ICIS price assessments are based on information gathered from a wide cross section of the market, comprising consumers, producers, traders and distributors. Confirmed deals, verified by both buyer and seller, provide the foundation of our price assessments, giving you a robust reference for your negotiations.
ICIS collects pricing data on a wide range of chemical, energy and fertilizer products, including Cyclohexane. Our extensive experience in price reporting means we can offer you access to historical data dating back more than 20 years for certain commodities.
Our time series of pricing data enables you to build and model trends, to get a view of where markets might be heading. The data service includes charting functionality, allowing you to chart and download multiple data series for manipulation in your own internal models. You can also export data to Excel via the ICIS dashboard service.
ICIS price assessments are based on information gathered from a wide cross-section of the market, comprising consumers, producers, traders and distributors from more than 250 reporters world-wide. Confirmed deals, verified by both buyer and seller, provide the foundation of our price assessments.
Our in-depth market knowledge drives our specialist focus, as we recognise the importance of individual market dynamics and not a one-size-fits-all approach.
Over 25 years of reporting on key chemicals markets, including Cyclohexane, has brought global recognition of our methodology as being unbiased, authoritative and rigorous in preserving our editorial integrity. Our global network of reporters in Houston, London, Singapore, Shanghai, Guangzhou, Mumbai, Perth and Moscow ensures unrivalled coverage of established and emerging markets.